The Long Run with Luke Timmerman cover image

Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

The Long Run with Luke Timmerman

00:00

How Many Years Have You Been in Pharma Business Development?

I started off in that oncology finance role, which is the Millennium was the oncology part. Then I became the first employee to move from Millennium to Parent to Keda. And so there I actually then moved away from pure finance into an actual sort of BD practitioner role. The one that I'm most proud of actually is the acquisition of that company in Virigin,. That Takeda has now gotten approved outside the US and still in front of the FDA here.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app